Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Equity Average (2016 - 2025)

Marimed has reported Equity Average over the past 15 years, most recently at $52.2 million for Q4 2025.

  • Quarterly Equity Average fell 17.45% to $52.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.2 million through Dec 2025, down 17.45% year-over-year, with the annual reading at $54.3 million for FY2025, 14.81% down from the prior year.
  • Equity Average was $52.2 million for Q4 2025 at Marimed, down from $55.6 million in the prior quarter.
  • Over five years, Equity Average peaked at $80.4 million in Q3 2023 and troughed at $11.4 million in Q1 2021.
  • The 5-year median for Equity Average is $56.5 million (2025), against an average of $53.3 million.
  • Year-over-year, Equity Average soared 1482.31% in 2021 and then decreased 17.69% in 2025.
  • A 5-year view of Equity Average shows it stood at $35.8 million in 2021, then surged by 52.49% to $54.6 million in 2022, then soared by 36.23% to $74.4 million in 2023, then fell by 15.03% to $63.2 million in 2024, then dropped by 17.45% to $52.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Equity Average are $52.2 million (Q4 2025), $55.6 million (Q3 2025), and $57.4 million (Q2 2025).